Skip to main content
. 2018 Sep 24;2018(9):CD011798. doi: 10.1002/14651858.CD011798.pub2

Comparison 7. Vildagliptin versus sitagliptin.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 HbA1c 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2 Fasting blood glucose 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3 Death (all causes) 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
4 Hypoglycaemia 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
5 Discontinuation of medication due to adverse events 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
6 Peripheral oedema 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
7 Pancreatitis 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
8 Liver impairment 1   Risk Ratio (IV, Random, 95% CI) Totals not selected